Baxter International Inc. (BAX)

63.83
0.80 1.27
NYSE : Health Technology
Prev Close 63.03
Open 63.36
Day Low/High 62.73 / 64.20
52 Wk Low/High 61.05 / 78.38
Volume 5.97M
Avg Volume 3.23M
Exchange NYSE
Shares Outstanding 532.14M
Market Cap 32.76B
EPS 1.30
P/E Ratio 27.86
Div & Yield 0.76 (1.10%)

Latest News

Baxter Highlights Data At ISPOR Europe 2018 On Clinical And Economic Benefits When Addressing Malnutrition, Intraoperative Bleeding

Baxter Highlights Data At ISPOR Europe 2018 On Clinical And Economic Benefits When Addressing Malnutrition, Intraoperative Bleeding

Baxter International Inc. (NYSE:BAX), a leading global medical products company, is presenting four health economics and outcomes research (HEOR) analyses this week at the International Society for Pharmacoeconomics and Outcomes Research (ISPOR) Europe...

Baxter Introduces New Tisseel Prima Syringe At 2018 American Association Of Gynecologic Laparoscopists Meeting

Baxter Introduces New Tisseel Prima Syringe At 2018 American Association Of Gynecologic Laparoscopists Meeting

Baxter International Inc. (NYSE:BAX), a global leader in advancing surgical innovation, today unveiled the latest design enhancements for its fibrin sealant product, the Tisseel Prima syringe, at the 2018 American Association of Gynecologic Laparoscopists...

Baxter To Present At Citi's 2018 Global Healthcare Conference

Baxter To Present At Citi's 2018 Global Healthcare Conference

Baxter International Inc. (NYSE:BAX), a leading global medical products company, will present at Citi's 2018 Global Healthcare Conference on Thursday, December 6, 2018, in New York.

Baxter International Breaks Its February/April Lows: Now What?

Baxter International Breaks Its February/April Lows: Now What?

BAX is now in a weak technical position.

A One-Two Punch to the Bears: Cramer's 'Mad Money' Recap (Thursday 11/1/18)

A One-Two Punch to the Bears: Cramer's 'Mad Money' Recap (Thursday 11/1/18)

Jim Cramer's been saying that that if the Fed or the president blink in their wars against inflation and China you could have an up day. That's what we got.

Jim Cramer: Even Safe-Haven Big-Cap Drug Stocks Are Now Broken

Jim Cramer: Even Safe-Haven Big-Cap Drug Stocks Are Now Broken

Once the safest stocks in the book, the big-cap drug companies are now toxic.

Baxter Reports Third-Quarter 2018 Results And Updates Financial Outlook For Full-Year 2018

Baxter Reports Third-Quarter 2018 Results And Updates Financial Outlook For Full-Year 2018

Baxter International Inc. (NYSE:BAX), a leading global medical products company, today reported results for the third quarter of 2018 and updated its full-year 2018 financial outlook.

Baxter Highlights Fifteen Studies Presented At ASN: Kidney Week 2018 On HDx Therapy Enabled By Theranova And Sharesource Remote Patient Management, Adding To Significantly Growing Global Clinical Evidence (Photo: Business Wire)

Baxter Highlights Fifteen Studies Presented At ASN: Kidney Week 2018 On HDx Therapy Enabled By Theranova And Sharesource Remote Patient Management, Adding To Significantly Growing Global Clinical Evidence (Photo: Business Wire)

Baxter International Inc. (NYSE:BAX), a global innovator in renal care, highlighted findings from HDx (expanded hemodialysis) and peritoneal dialysis (PD) studies presented at the American Society of Nephrology (ASN): Kidney Week, Oct.

Baxter Receives CE Mark For PrisMax, The Next-Generation System For Continuous Renal Replacement And Organ Support Therapies (Photo: Business Wire)

Baxter Receives CE Mark For PrisMax, The Next-Generation System For Continuous Renal Replacement And Organ Support Therapies (Photo: Business Wire)

Baxter International Inc. (NYSE:BAX), a global leader in acute care, announced today the company received CE mark of both its PrisMax system and its TherMax blood warmer.

Baxter Announces U.S. Regulatory Filing For PrisMax Acute Care System And Presentation Of 15 Abstracts To Start ASN: Kidney Week 2018

Baxter Announces U.S. Regulatory Filing For PrisMax Acute Care System And Presentation Of 15 Abstracts To Start ASN: Kidney Week 2018

Baxter International Inc. (NYSE:BAX), a leading global medical products company, announced it has submitted the PrisMax system for 510(k) clearance to the U.

Tariffs, Trade, and Now, Turkey: Cramer's 'Mad Money' Recap (Monday 8/13/18)

Tariffs, Trade, and Now, Turkey: Cramer's 'Mad Money' Recap (Monday 8/13/18)

Jim Cramer says investors should turn this Turkey-induced selloff into a buying opportunity.

Baxter To Showcase Critical Care Innovation At The 2018 European Society Of Intensive Care Medicine Congress

Baxter To Showcase Critical Care Innovation At The 2018 European Society Of Intensive Care Medicine Congress

Baxter International Inc. (NYSE:BAX), a leading global medical products company, will highlight its latest innovations in critical care at the 2018 European Society of Intensive Care Medicine (ESICM) congress in Paris from Oct.

Baxter And ASPEN Launch "SmartPN" Tools To Reinforce Appropriate Use Of Parenteral Nutrition

Baxter And ASPEN Launch "SmartPN" Tools To Reinforce Appropriate Use Of Parenteral Nutrition

Today the American Society for Parenteral and Enteral Nutrition (ASPEN), an organization which drives the science and practice of clinical nutrition, and Baxter International Inc.

Baxter To Present At The 27th Annual Credit Suisse Healthcare Conference

Baxter To Present At The 27th Annual Credit Suisse Healthcare Conference

Baxter International Inc. (NYSE:BAX), a leading global medical products company, will present at the 27th Annual Credit Suisse Healthcare Conference in Scottsdale, Ariz.

The Baxter And Mayo Clinic's New Renal Care Center Of Excellence Is Located On Mayo Clinic's Campus At Jacksonville, Florida (Photo: Business Wire)

The Baxter And Mayo Clinic's New Renal Care Center Of Excellence Is Located On Mayo Clinic's Campus At Jacksonville, Florida (Photo: Business Wire)

Baxter International Inc. (NYSE:BAX), a global innovator in renal care, and Mayo Clinic today announced a new collaboration to develop a renal care center of excellence in the U.

Jim Cramer: These Are the Stocks to Buy on Canada Deal and the 4th Quarter

Jim Cramer: These Are the Stocks to Buy on Canada Deal and the 4th Quarter

Straying from these names could land you in quicksand as the 4th quarter begins.

Baxter Collaborates With University Of Southern California Center For Body Computing To Advance Digital Health Solutions

Baxter Collaborates With University Of Southern California Center For Body Computing To Advance Digital Health Solutions

Baxter International Inc. (NYSE:BAX), a leading global medical products company, announced today a collaboration with the University of Southern California (USC) Center for Body Computing (CBC) to research and develop innovative digital solutions designed...

New Data On Floseal Surgical Hemostat Quantifies Clinical And Healthcare Resource Outcomes In Spine Surgery Cases

New Data On Floseal Surgical Hemostat Quantifies Clinical And Healthcare Resource Outcomes In Spine Surgery Cases

Baxter International Inc. (NYSE:BAX), a global leader in advancing surgical innovation, announced the publication of two new analyses of real-world data regarding the use of Floseal Hemostatic Matrix in spinal surgeries.

Baxter Announces U.S. FDA Clearance Of ALTAPORE Bioactive Bone Graft In Posterolateral Spine Surgery

Baxter Announces U.S. FDA Clearance Of ALTAPORE Bioactive Bone Graft In Posterolateral Spine Surgery

Baxter International Inc. (NYSE:BAX), a global leader in advancing surgical innovation, today announced U.

Baxter Recognized As One Of Working Mother's 2018 '100 Best Companies'

Baxter Recognized As One Of Working Mother's 2018 '100 Best Companies'

Baxter International Inc. (NYSE: BAX), a leading global medical products company, today announced that it has been named to Working Mother magazine's 2018 '100 Best Companies' list.

Baxter To Host Third Quarter 2018 Financial Results Conference Call For Investors

Baxter To Host Third Quarter 2018 Financial Results Conference Call For Investors

Baxter International Inc. (NYSE:BAX), a leading global medical products company, will host a conference call to discuss its third quarter 2018 financial results on Wednesday, October 31, 2018, at 7:30 a.

Jim Cramer: Here's Why the Market Rally Has Staying Power

Jim Cramer: Here's Why the Market Rally Has Staying Power

For most of this year the market has been led by growth stocks.

Baxter Named To Dow Jones Sustainability Index For 19th Consecutive Year, Recognized For Its Dedication To Corporate Responsibility

Baxter Named To Dow Jones Sustainability Index For 19th Consecutive Year, Recognized For Its Dedication To Corporate Responsibility

Baxter International Inc. (NYSE:BAX), a leading global medical products company, today announced that it has been named to the Dow Jones Sustainability World Index (DJSI World Index) and the Dow Jones Sustainability North America Index (DJSI North...

Baxter Announces U.S. FDA Clearance Of New Bone Graft Substitute, Actifuse Flow

Baxter Announces U.S. FDA Clearance Of New Bone Graft Substitute, Actifuse Flow

Baxter International Inc. (NYSE:BAX), a global leader in advancing surgical innovation, today announced U.

Baxter Announces CE Mark And Regulatory Approval Of New Evo IQ Infusion System For The United Kingdom, Ireland, Australia And New Zealand

Baxter Announces CE Mark And Regulatory Approval Of New Evo IQ Infusion System For The United Kingdom, Ireland, Australia And New Zealand

Baxter International Inc. (NYSE:BAX), a leader in innovative technology for medication delivery, today announced the CE marking of the Evo IQ Infusion System.

The Dip in Baxter International Should Soon Be a Buying Opportunity

The Dip in Baxter International Should Soon Be a Buying Opportunity

BAX declined recently to break the rising 50-day moving average line.

Baxter Reports Second-Quarter 2018 Results And Increases Earnings Outlook For Full-Year 2018

Baxter Reports Second-Quarter 2018 Results And Increases Earnings Outlook For Full-Year 2018

Baxter International Inc. (NYSE:BAX), a leading global medical products company, today reported results for the second quarter of 2018 and increased its full-year 2018 earnings guidance.

Baxter Declares Quarterly Dividend

Baxter Declares Quarterly Dividend

Baxter International Inc. (NYSE:BAX), a leading global medical products company, today announced that its Board of Directors has declared a quarterly cash dividend of $0.

TheStreet Quant Rating: B+ (Buy)